RxDoctor Payments Data

Lisa Gilmore, APRN

Nurse Practitioner · Augusta, KSNPI 1205272259

Payments from drug & device makers

$3,614in general payments, 2019–2025

Across 226 payments — averaging $15.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$568
  • Novo Nordisk$505
  • AbbVie$458
  • AstraZeneca$404
  • Astellas Pharma US Inc$395
  • Lilly USA, LLC$150
  • plus $1K from 28 others

What the payments were for

  • Food & beverage$3,614100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,614 in reported general payments places this provider in the 90th percentile of 1,326 nurse practitioner providers in Kansas.

See all nurse practitioner providers in Kansas

Medicare billing

Part B allowed, 2024
$149,188
Medicare patients
270
Services billed
4,425

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban100$72,790
LinzessLinaclotide32$19,307
OzempicSemaglutide18$17,542
Breztri AerosphereBudesonide/Glycopyr/Formoterol27$17,375
MounjaroTirzepatide15$16,457
MyrbetriqMirabegron21$15,616
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$14,470
Janumet XrSitagliptin Phos/Metformin Hcl15$11,652
Emgality PenGalcanezumab-Gnlm14$10,400
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen388$7,766
BelsomraSuvorexant14$6,267
Breo ElliptaFluticasone/Vilanterol13$5,205
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen167$5,099
JardianceEmpagliflozin12$3,414
Potassium Chloride164$3,214

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$29$75,500113 claims
GSKTrelegy Ellipta, Breo Ellipta$30$19,67632 claims
AbbVieLinzess$458$19,30732 claims
MerckJanumet Xr, Belsomra$32$17,91929 claims
Novo NordiskOzempic$505$17,54218 claims
AstraZenecaBreztri Aerosphere$404$17,37527 claims
Lilly USA, LLCMounjaro$150$16,45715 claims
Astellas Pharma US IncMyrbetriq$395$15,61621 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,326 nurse practitioner providers in Kansas.

Other nurse practitioner in Augusta

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →